共 286 条
- [1] Brugarolas J(2007)Renal-cell carcinoma-molecular pathways and therapies N Engl J Med 356 185-187
- [2] Motzer RJ(2013)Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 43-49
- [3] Hutson TE(2007)Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 115-124
- [4] Tomczak P(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
- [5] Michaelson MD(2007)Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2103-2111
- [6] Bukowski RM(2010)Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial J Clin Oncol 28 1061-1068
- [7] Rixe O(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-247
- [8] Oudard S(1981)Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 29 577-580
- [9] Negrier S(2009)Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 5794-5799
- [10] Szczylik C(2011)Prognostic factors and predictive models in renal cell carcinoma: a contemporary review Eur Urol 60 644-661